Cargando…
Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma
Rationale: Lung adenocarcinoma (LUAD) is an aggressive disease with high propensity of metastasis. Among patients with early-stage disease, more than 30% of them may relapse or develop metastasis. There is an unmet medical need to stratify patients with early-stage LUAD according to their risk of re...
Autores principales: | Cheng, Wei-Chung, Chang, Chun-Yu, Lo, Chia-Chien, Hsieh, Chih-Ying, Kuo, Ting-Ting, Tseng, Guan-Chin, Wong, Sze-Ching, Chiang, Shu-Fen, Huang, Kevin Chih-Yang, Lai, Liang-Chuan, Lu, Tzu-Pin, Chao, K.S. Clifford, Sher, Yuh-Pyng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914355/ https://www.ncbi.nlm.nih.gov/pubmed/33664854 http://dx.doi.org/10.7150/thno.53176 |
Ejemplares similares
-
Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
por: Chou, Cheng-Wei, et al.
Publicado: (2019) -
Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
por: Wong, Sze‐Ching, et al.
Publicado: (2023) -
ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
por: Lin, Chen-Yuan, et al.
Publicado: (2017) -
Targeting positive feedback between BASP1 and EGFR as a therapeutic strategy for lung cancer progression
por: Lin, Ching-Chan, et al.
Publicado: (2020) -
Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation
por: Lai, Liang-Chuan, et al.
Publicado: (2011)